vs
Side-by-side financial comparison of OLAPLEX HOLDINGS, INC. (OLPX) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $105.1M, roughly 1.6× OLAPLEX HOLDINGS, INC.). OLAPLEX HOLDINGS, INC. runs the higher net margin — -12.5% vs -82.0%, a 69.5% gap on every dollar of revenue. On growth, OLAPLEX HOLDINGS, INC. posted the faster year-over-year revenue change (4.3% vs -22.7%). OLAPLEX HOLDINGS, INC. produced more free cash flow last quarter ($32.6M vs $-36.6M). Over the past eight quarters, OLAPLEX HOLDINGS, INC.'s revenue compounded faster (3.1% CAGR vs -11.5%).
Olaplex Holdings, Inc. is a specialty beauty company developing and selling patented bond-repair hair care products. It runs three core segments: professional salon distribution, direct-to-consumer sales, and third-party retail, serving customers across North America, Europe, and Asia-Pacific with products that repair and protect damaged hair.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
OLPX vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $105.1M | $164.7M |
| Net Profit | $-13.1M | $-135.0M |
| Gross Margin | 68.0% | — |
| Operating Margin | -4.3% | -43.3% |
| Net Margin | -12.5% | -82.0% |
| Revenue YoY | 4.3% | -22.7% |
| Net Profit YoY | -48.9% | -104.8% |
| EPS (diluted) | $-0.02 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $105.1M | $164.7M | ||
| Q3 25 | $114.6M | $211.0M | ||
| Q2 25 | $106.3M | $178.9M | ||
| Q1 25 | $97.0M | $1.2B | ||
| Q4 24 | $100.7M | $213.2M | ||
| Q3 24 | $119.1M | $196.8M | ||
| Q2 24 | $103.9M | $186.7M | ||
| Q1 24 | $98.9M | $210.1M |
| Q4 25 | $-13.1M | $-135.0M | ||
| Q3 25 | $11.1M | $15.9M | ||
| Q2 25 | $-7.7M | $-64.8M | ||
| Q1 25 | $465.0K | $866.6M | ||
| Q4 24 | $-8.8M | $-65.9M | ||
| Q3 24 | $14.8M | $-106.7M | ||
| Q2 24 | $5.8M | $-99.2M | ||
| Q1 24 | $7.7M | $-91.6M |
| Q4 25 | 68.0% | — | ||
| Q3 25 | 69.1% | — | ||
| Q2 25 | 71.2% | — | ||
| Q1 25 | 69.5% | — | ||
| Q4 24 | 66.3% | — | ||
| Q3 24 | 68.6% | — | ||
| Q2 24 | 69.7% | — | ||
| Q1 24 | 72.1% | — |
| Q4 25 | -4.3% | -43.3% | ||
| Q3 25 | 3.7% | 1.4% | ||
| Q2 25 | -1.1% | -19.5% | ||
| Q1 25 | 8.7% | 82.5% | ||
| Q4 24 | 3.0% | -76.2% | ||
| Q3 24 | 23.5% | -27.7% | ||
| Q2 24 | 15.7% | -21.5% | ||
| Q1 24 | 19.8% | -21.6% |
| Q4 25 | -12.5% | -82.0% | ||
| Q3 25 | 9.7% | 7.5% | ||
| Q2 25 | -7.3% | -36.3% | ||
| Q1 25 | 0.5% | 73.7% | ||
| Q4 24 | -8.7% | -30.9% | ||
| Q3 24 | 12.4% | -54.2% | ||
| Q2 24 | 5.6% | -53.1% | ||
| Q1 24 | 7.8% | -43.6% |
| Q4 25 | $-0.02 | $-1.63 | ||
| Q3 25 | $0.02 | $0.20 | ||
| Q2 25 | $-0.01 | $-0.83 | ||
| Q1 25 | $0.00 | $10.04 | ||
| Q4 24 | $-0.01 | $-0.85 | ||
| Q3 24 | $0.02 | $-1.39 | ||
| Q2 24 | $0.01 | $-1.29 | ||
| Q1 24 | $0.01 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $318.7M | $1.9B |
| Total DebtLower is stronger | $352.3M | — |
| Stockholders' EquityBook value | $879.4M | $-205.3M |
| Total Assets | $1.5B | $2.9B |
| Debt / EquityLower = less leverage | 0.40× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $318.7M | $1.9B | ||
| Q3 25 | $286.4M | $1.7B | ||
| Q2 25 | $289.3M | $2.0B | ||
| Q1 25 | $580.9M | $2.0B | ||
| Q4 24 | $586.0M | $1.1B | ||
| Q3 24 | $538.8M | $1.0B | ||
| Q2 24 | $507.9M | $1.1B | ||
| Q1 24 | $507.5M | $884.8M |
| Q4 25 | $352.3M | — | ||
| Q3 25 | $352.1M | — | ||
| Q2 25 | $351.9M | — | ||
| Q1 25 | $649.1M | — | ||
| Q4 24 | $650.5M | — | ||
| Q3 24 | $651.8M | — | ||
| Q2 24 | $653.1M | — | ||
| Q1 24 | $654.4M | — |
| Q4 25 | $879.4M | $-205.3M | ||
| Q3 25 | $888.7M | $-155.8M | ||
| Q2 25 | $874.2M | $-206.5M | ||
| Q1 25 | $878.3M | $-185.8M | ||
| Q4 24 | $874.4M | $-1.1B | ||
| Q3 24 | $879.7M | $-1.1B | ||
| Q2 24 | $863.3M | $-980.2M | ||
| Q1 24 | $855.7M | $-893.9M |
| Q4 25 | $1.5B | $2.9B | ||
| Q3 25 | $1.5B | $2.6B | ||
| Q2 25 | $1.5B | $2.6B | ||
| Q1 25 | $1.8B | $2.7B | ||
| Q4 24 | $1.8B | $1.7B | ||
| Q3 24 | $1.8B | $1.8B | ||
| Q2 24 | $1.8B | $1.9B | ||
| Q1 24 | $1.8B | $1.8B |
| Q4 25 | 0.40× | — | ||
| Q3 25 | 0.40× | — | ||
| Q2 25 | 0.40× | — | ||
| Q1 25 | 0.74× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 0.74× | — | ||
| Q2 24 | 0.76× | — | ||
| Q1 24 | 0.76× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $32.7M | $-34.3M |
| Free Cash FlowOCF − Capex | $32.6M | $-36.6M |
| FCF MarginFCF / Revenue | 31.0% | -22.3% |
| Capex IntensityCapex / Revenue | 0.1% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $58.3M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $32.7M | $-34.3M | ||
| Q3 25 | $8.0M | $-66.3M | ||
| Q2 25 | $20.9M | $-58.3M | ||
| Q1 25 | $-2.9M | $870.1M | ||
| Q4 24 | $49.7M | $-30.0M | ||
| Q3 24 | $33.5M | $-77.0M | ||
| Q2 24 | $16.2M | $-71.5M | ||
| Q1 24 | $43.7M | $70.8M |
| Q4 25 | $32.6M | $-36.6M | ||
| Q3 25 | $7.9M | $-69.7M | ||
| Q2 25 | $20.8M | $-59.6M | ||
| Q1 25 | $-3.0M | $868.4M | ||
| Q4 24 | $49.2M | $-33.8M | ||
| Q3 24 | $33.3M | $-77.5M | ||
| Q2 24 | $16.1M | $-78.8M | ||
| Q1 24 | $43.3M | $61.2M |
| Q4 25 | 31.0% | -22.3% | ||
| Q3 25 | 6.9% | -33.1% | ||
| Q2 25 | 19.6% | -33.3% | ||
| Q1 25 | -3.1% | 73.8% | ||
| Q4 24 | 48.9% | -15.8% | ||
| Q3 24 | 28.0% | -39.4% | ||
| Q2 24 | 15.5% | -42.2% | ||
| Q1 24 | 43.7% | 29.1% |
| Q4 25 | 0.1% | 1.4% | ||
| Q3 25 | 0.1% | 1.6% | ||
| Q2 25 | 0.1% | 0.7% | ||
| Q1 25 | 0.0% | 0.1% | ||
| Q4 24 | 0.4% | 1.8% | ||
| Q3 24 | 0.1% | 0.3% | ||
| Q2 24 | 0.1% | 4.0% | ||
| Q1 24 | 0.5% | 4.6% |
| Q4 25 | — | — | ||
| Q3 25 | 0.72× | -4.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | -6.27× | 1.00× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.26× | — | ||
| Q2 24 | 2.81× | — | ||
| Q1 24 | 5.64× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OLPX
| Sales Channel Directly To Consumer | $43.6M | 42% |
| Sales Channel Through Intermediary Professional | $36.8M | 35% |
| Sales Channel Through Intermediary Specialty Retail | $24.7M | 23% |
PTCT
Segment breakdown not available.
